May 10, 2019 - Jazz (JAZZ) is well positioned to outperform the market, as it exhibits above-average growth in financials.
May 08, 2019 - Jazz Pharmaceuticals (JAZZ) reports encouraging first-quarter 2019 earnings and revenues and maintains its guidance for 2019.
May 08, 2019 - The drugmaker reported strong revenue and earnings growth thanks largely to solid growth for narcolepsy drug Xyrem.
May 08, 2019 - JAZZ earnings call for the period ending March 31, 2019.
May 08, 2019 - Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) Q1 2019 Results Earnings Conference Call May 7, 2019, 04:30 PM ET Company Participants Katherine Littrell - Head of Investor Relations Bruce Cozadd - Chairman
May 07, 2019 - Jazz (JAZZ) delivered earnings and revenue surprises of 16.14% and 7.89%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
May 07, 2019 - The following slide deck was published by Jazz Pharmaceuticals plc in conjunction with their 2019 Q1 earnings call.
May 07, 2019 -
Verna Hart — the Harlem-born artist who developed her childhood passions into a successful career by blending painting and music to praise jazz and its performers — will be remembered Thursdayat funeral services in Queens.
Hart died in her sleep April 26 in Wilmington, Del., according to her family....
May 05, 2019 -
Music superstar Diana Ross was on a high after her performance at the New Orleans Jazz & Heritage Festival over the weekend, but that was punctured by an intrusive pat-down at the airport that left her feeling “violated,” the singer said just hours later via Twitter.
“OK so on one hand I’m treated...
May 02, 2019 - JAZZ vs. ZTS: Which Stock Is the Better Value Option?